IRIS
DAVI', Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.684
AS - Asia 8.614
EU - Europa 8.596
SA - Sud America 1.534
AF - Africa 126
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 5
Totale 30.591
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.467
SG - Singapore 3.172
CN - Cina 2.721
UA - Ucraina 1.869
IE - Irlanda 1.540
TR - Turchia 1.417
BR - Brasile 1.279
SE - Svezia 991
GB - Regno Unito 937
IT - Italia 799
DE - Germania 739
FR - Francia 678
VN - Vietnam 499
FI - Finlandia 427
IN - India 375
RU - Federazione Russa 328
CA - Canada 112
AR - Argentina 109
PL - Polonia 77
MX - Messico 71
HK - Hong Kong 65
ZA - Sudafrica 55
EC - Ecuador 54
BD - Bangladesh 50
IQ - Iraq 44
AT - Austria 39
CZ - Repubblica Ceca 39
JP - Giappone 38
KR - Corea 38
ID - Indonesia 36
ES - Italia 34
EU - Europa 26
MA - Marocco 25
PK - Pakistan 23
CO - Colombia 20
IL - Israele 19
VE - Venezuela 19
NL - Olanda 18
BE - Belgio 15
PY - Paraguay 15
LT - Lituania 14
CL - Cile 13
IR - Iran 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
SA - Arabia Saudita 12
AZ - Azerbaigian 11
EG - Egitto 10
UY - Uruguay 10
PE - Perù 9
RO - Romania 9
TN - Tunisia 9
AL - Albania 7
BG - Bulgaria 7
DZ - Algeria 7
HN - Honduras 7
KE - Kenya 7
JO - Giordania 6
KZ - Kazakistan 6
TW - Taiwan 6
BO - Bolivia 5
CR - Costa Rica 5
OM - Oman 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BZ - Belize 4
LB - Libano 4
QA - Qatar 4
TT - Trinidad e Tobago 4
AU - Australia 3
CH - Svizzera 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
KG - Kirghizistan 3
MY - Malesia 3
NG - Nigeria 3
NI - Nicaragua 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
EE - Estonia 2
GR - Grecia 2
JM - Giamaica 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BB - Barbados 1
BW - Botswana 1
CI - Costa d'Avorio 1
Totale 30.573
Salva come PNG Salva come JPEG
Città #
Singapore 2.437
Jacksonville 2.154
Dublin 1.531
Chandler 1.452
Princeton 744
Izmir 732
Southend 656
Dallas 652
Ashburn 623
Nanjing 603
Beijing 600
Wilmington 383
Cambridge 340
Santa Clara 340
Los Angeles 334
Dearborn 298
Altamura 295
Nanchang 224
Tongling 210
Ho Chi Minh City 189
Buffalo 184
New York 184
The Dalles 167
Ann Arbor 164
Munich 140
São Paulo 133
Chieti 127
Boardman 111
Hebei 103
Shenyang 103
Woodbridge 101
Hanoi 97
Tianjin 91
Kunming 88
Moscow 71
Washington 70
Jiaxing 69
Grevenbroich 67
Hong Kong 63
Helsinki 60
Norwalk 56
Changsha 54
Redondo Beach 54
Warsaw 54
Montreal 48
Brooklyn 44
Johannesburg 38
Seoul 37
Council Bluffs 36
Denver 36
Tokyo 36
Hangzhou 35
Augusta 33
Houston 33
Turku 33
Orange 31
Stockholm 31
Chennai 30
Poplar 30
Seattle 30
Toronto 30
Brno 28
Jinan 28
Rio de Janeiro 28
Changchun 27
Lanzhou 27
Haiphong 26
Orem 26
Hefei 25
San Mateo 25
Boston 24
Chicago 24
Atlanta 23
London 23
Brasília 22
Ningbo 22
Rome 22
San Francisco 22
Belo Horizonte 21
Guayaquil 21
Curitiba 20
Mexico City 20
Falls Church 19
Pescara 19
Phoenix 19
Shanghai 19
Baghdad 18
Frankfurt am Main 18
Leawood 18
Nuremberg 18
Da Nang 17
Quito 17
Mumbai 16
Biên Hòa 15
Brussels 15
Guarulhos 15
Querétaro 14
Ribeirão Preto 14
Sorocaba 14
Zhengzhou 14
Totale 18.602
Salva come PNG Salva come JPEG
Nome #
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 169
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 167
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 159
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 159
Pentraxin 3 and platelet activation in obese patients after gastric banding 156
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 153
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 144
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 142
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 141
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 140
Determinants of platelet activation in hypertensives with microalbuminuria. 138
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 138
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 137
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 135
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 135
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 135
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 135
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 131
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 127
In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients. 127
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. 127
Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis 127
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 127
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 127
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 126
Platelets and Diabetes 126
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 126
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 126
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 124
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 123
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 123
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 122
Increased soluble CD40L levels in cystic fibrosis 122
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 122
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 122
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 121
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 121
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 120
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 119
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 119
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 118
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 118
Platelets and diabetes mellitus 118
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 117
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 117
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 117
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 116
Coagulation and infective endocarditis: sooner or later 116
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 116
Leptin increase is associated with markers of the hemostatic system in obese healthy women 115
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 115
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 114
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 114
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 114
Insulin resistance as a determinant of platelet activation in obese women. 113
Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards 113
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 113
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 112
The relationship between clinical events and JAK2V617F mutation status in a cohort of 75 patients with essential thrombocythemia 112
[The "problem obesity": viewpoint of the internist] 112
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 112
Platelet activation in obesity and metabolic syndrome. 111
[The "problem obesity": viewpoint of the internist]. 111
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 111
Aspirin, platelets, and cancer: The point of view of the internist. 111
A comparison of five maintenance therapies for reflux esophagitis 110
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 109
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 109
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 109
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 108
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 108
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 108
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 108
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 108
Association between serum leptin levels and 24-hour blood pressure in obese women. 108
Antipsychotic prescription and mortality in hospitalized older persons 108
Homocysteine modulates the CD40/CD40L system 107
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 107
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 107
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications 107
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 106
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 106
Determinants of platelet activation in hypertensives with microalbuminuria. 105
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 105
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 104
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 104
Use of non-steroidal anti-inflammatory drugs and analgesics in a cohort of hospitalized elderly patients: Results from the REPOSI study 104
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 104
Soluble forms of RAGE in internal medicine. 104
Soluble RAGE in type 2 diabetes: association with oxidative stress. 102
Atherothrombotic disease and the metabolic syndrome. 102
Antiplatelet Agents. Thromboxane receptors antagonists and/or synthase inhibitors 102
Diabetes mellitus and thrombosis 102
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 102
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 101
[Analysis of various blood coagulation indices in a group of hypertensive, arteriosclerotic and dyslipidemic patients with post-prandial hypertriglyceridemia]. 100
Thromboxane-dependent CD40L release in type 2 diabetes mellitus 100
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 100
Obesity-driven inflammation and colorectal cancer 100
A Complex Interaction between Rickettsia conorii and Dickkopf-1 - Potential Role in Immune Evasion Mechanisms in Endothelial Cells 100
Totale 11.868
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.574
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.574
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.135 0 0 0 0 0 487 24 20 157 326 39 82
2021/20221.396 23 29 11 218 104 20 22 121 121 53 216 458
2022/20234.428 432 654 236 425 385 931 302 299 529 45 97 93
2023/20241.949 139 78 136 50 118 633 504 72 18 33 14 154
2024/20255.400 463 1.089 862 67 77 134 82 223 519 207 566 1.111
2025/20266.050 911 482 1.396 1.875 951 435 0 0 0 0 0 0
Totale 31.688